| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Po-Lin Kuo | |
| Szu-Chia Chen | |||
| P2860 | cites work | Galectin-3-positive cell infiltration in human diabetic nephropathy | Q75434736 |
| Tubular atrophy and interstitial fibrosis after renal transplantation is dependent on galectin-3 | Q83393247 | ||
| Immunohistochemical localization of galectins-1 and -3 and monitoring of tissue galectin-binding sites during tubular regeneration after renal ischemia reperfusion in the rat | Q85075919 | ||
| Alternations of galectin levels after renal transplantation | Q88195360 | ||
| Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor | Q42467384 | ||
| Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies | Q42474421 | ||
| Shuttling of galectin-3 between the nucleus and cytoplasm. | Q42813718 | ||
| Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. | Q43786750 | ||
| Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. | Q44248315 | ||
| Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies | Q44853464 | ||
| A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury | Q46461255 | ||
| Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7. | Q46505356 | ||
| Exploring the role of galectin 3 in kidney function: a genetic approach. | Q46706379 | ||
| Metabolic syndrome and chronic kidney disease in Okinawa, Japan | Q46891095 | ||
| The fibrosis marker galectin-3 and outcome in the general population | Q48821773 | ||
| Patient survival after renal transplantation; more than 25 years follow-up. | Q50939199 | ||
| Renal function largely influences Galectin-3 prognostic value in heart failure. | Q50995380 | ||
| Renal function and risk of hip and vertebral fractures in older women. | Q51924728 | ||
| Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis | Q61187743 | ||
| Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis | Q24649584 | ||
| Role of Galectin-3 in Obesity and Impaired Glucose Homeostasis | Q26771826 | ||
| Thrombospondin-2 Is Essential for Myocardial Matrix Integrity: Increased Expression Identifies Failure-Prone Cardiac Hypertrophy | Q27987455 | ||
| Galectins. Structure and function of a large family of animal lectins | Q28246794 | ||
| Up-regulation of galectin-3 in acute renal failure of the rat | Q28344724 | ||
| Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study | Q33529398 | ||
| Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury | Q33873592 | ||
| Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis | Q34316944 | ||
| Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction | Q34364121 | ||
| Galectin-3: an open-ended story | Q34494555 | ||
| Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis | Q34501897 | ||
| Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction | Q34528187 | ||
| The regulation of inflammation by galectin-3. | Q34991925 | ||
| Galectin-3: a novel mediator of heart failure development and progression | Q34995162 | ||
| Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis | Q35070734 | ||
| Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. | Q35109460 | ||
| Risk factors for progressive chronic kidney disease | Q35159360 | ||
| Role of galectin-3 in diabetic nephropathy | Q35182376 | ||
| Changes in the expression and subcellular distribution of galectin-3 in clear cell renal cell carcinoma | Q35563015 | ||
| Regulation of cellular homeostasis by galectins | Q35646643 | ||
| Extracellular functions of galectin-3. | Q35646647 | ||
| Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia | Q35762413 | ||
| Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies | Q36003071 | ||
| Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure. | Q36522700 | ||
| Elevated galectin-3 precedes the development of CKD | Q37119904 | ||
| The immunological potential of galectin-1 and -3. | Q37343666 | ||
| Galectin-3 modulates ureteric bud branching in organ culture of the developing mouse kidney | Q38304117 | ||
| Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis | Q38497448 | ||
| Clinical significance of Galectin-3 in clear cell renal cell carcinoma | Q39725948 | ||
| High prevalence of chronic kidney disease in Thailand | Q39824512 | ||
| Effects of advanced glycosylation end products and rosiglitazone on the expression and secretion of galectin-3 in human renal mesangial cells. | Q39843247 | ||
| Macrophages and progressive renal disease in experimental hydronephrosis | Q40444282 | ||
| Galectins: a family of animal lectins that decipher glycocodes | Q41201922 | ||
| Epithelial galectin-3 during human nephrogenesis and childhood cystic diseases. | Q42446428 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney | Q9377 |
| organic chemistry | Q11351 | ||
| catalysis | Q82264 | ||
| lectin | Q408693 | ||
| kidney disease | Q1054718 | ||
| Galectin 3 | Q3094567 | ||
| genitourinary system | Q4712977 | ||
| P304 | page(s) | 565 | |
| P577 | publication date | 2016-01-01 | |
| 2016-04-14 | |||
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | The Role of Galectin-3 in the Kidneys | |
| P478 | volume | 17 |
| Q57456610 | Bioactive Compounds for the Treatment of Renal Disease |
| Q64065696 | Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus |
| Q57807540 | Elevated preoperative Galectin-3 is associated with acute kidney injury after cardiac surgery |
| Q99240850 | Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction |
| Q90169765 | Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs |
| Q36187612 | Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage |
| Q55383284 | Galectin-3 and incident cognitive impairment in REGARDS, a cohort of blacks and whites. |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q47329197 | Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). |
| Q64097454 | Galectin-3 as a prognostic biomarker for diabetic nephropathy |
| Q33754984 | Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation. |
| Q50126684 | Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus |
| Q90640127 | Galectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristane |
| Q49670112 | Galectin-3 regulation of wound healing and fibrotic processes: insights for chronic skin wound therapeutics |
| Q48159180 | Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. |
| Q47733264 | Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases |
| Q64897087 | Hepatic fibrosis scores and serum biomarkers in pediatric hepatology. |
| Q89486528 | High-sensitivity Troponin I Predicts Galectin-3 in Chronic Kidney Disease Patients |
| Q58698065 | Macrophages and Galectin 3 Control Bacterial Burden in Acute and Subacute Murine Leptospirosis That Determines Chronic Kidney Fibrosis |
| Q92302918 | Mechanisms of Polymyxin-Induced Nephrotoxicity |
| Q33733115 | PEA3 protects against gentamicin nephrotoxicity: role of mitochondrial dysfunction |
| Q30841381 | Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy |
| Q26738521 | Prognostic biomarkers in acute coronary syndrome |
| Q88154862 | The effects of galectin-3 depletion apheresis on induced skin inflammation in a porcine model |
Search more.